Author:
Kobayashi Kanao,Takahashi Satoshi,Yasuda Mitsuru,Miyazaki Jun,Wada Koichiro,Matsumoto Masahiro,Hayami Hiroshi,Yamamoto Shingo,Kiyota Hiroshi,Sato Junko,Matsumoto Tetsuya,Hasegawa Naoki,Kobayashi Intetsu,Masumori Naoya,Kimura Takahiro,Yamada Hiroki,Nakagawa Tohru,Kaneko Tomoyuki,Matsumoto Kazumasa,Fujimura Tetsuya,Kamei Jun,Ishikawa Kiyohito,Fujimoto Kiyohide,Nakai Yasushi,Shigemura Katsumi,Sadahira Takuya,Hinata Nobuyuki,Kitano Hiroyuki,Yamashita Masuo,Yasufuku Tomihiko,Komeda Hisao,Hiyama Yoshiki,Takahashi Yoshito,Kanamaru Sojun,Murakami Masaya,Arakawa Soichi,Yamada Daisuke,Mita Koji,Hamasuna Ryoichi,Tanaka Kazushi,Matsukawa Masanori,Takaoka Eiichiro,Shigeta Masanobu,Takenaka Tadasu,Nishino Masashi,Ishitoya Satoshi,Hayakawa Shohei,Okumura Kazuhiro,Ueda Masakatsu
Reference17 articles.
1. The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy;Ishikawa;J Infect Chemother,2011
2. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases;Ishikawa;J Infect Chemother,2015
3. The third national Japanese antimicrobial susceptibility pattern surveillance program: bacterial isolates from complicated urinary tract infection patients;Kobayashi;J Infect Chemother,2020
4. Japanese guideline for clinical research of antimicrobial agents on urogenital infections, Japanese society of Chemotherapy: Japanese guideline for clinical research of antimicrobial agents on urogenital infections. 2nd ed;J Infect Chemother,2016
5. Guidance on regulations for the transport of infectious substances 2017–2018: applicable from 1 January,2017